172 related articles for article (PubMed ID: 37495855)
1. ADAM12 expression is upregulated in cancer cells upon radiation and constitutes a prognostic factor in rectal cancer patients following radiotherapy.
Piotrowski KB; Blasco LP; Samsøe-Petersen J; Eefsen RL; Illemann M; Oria VO; Campos KIA; Lopresti AM; Albrechtsen R; Sørensen CS; Sun XF; Kveiborg M; Gnosa S
Cancer Gene Ther; 2023 Oct; 30(10):1369-1381. PubMed ID: 37495855
[TBL] [Abstract][Full Text] [Related]
2. Metalloprotease-disintegrin ADAM12 actively promotes the stem cell-like phenotype in claudin-low breast cancer.
Duhachek-Muggy S; Qi Y; Wise R; Alyahya L; Li H; Hodge J; Zolkiewska A
Mol Cancer; 2017 Feb; 16(1):32. PubMed ID: 28148288
[TBL] [Abstract][Full Text] [Related]
3. Serum-based measurements of stromal activation through ADAM12 associate with poor prognosis in colorectal cancer.
Ten Hoorn S; Waasdorp C; van Oijen MGH; Damhofer H; Trinh A; Zhao L; Smits LJH; Bootsma S; van Pelt GW; Mesker WE; Mol L; Goey KKH; Koopman M; Medema JP; Tuynman JB; Zlobec I; Punt CJA; Vermeulen L; Bijlsma MF
BMC Cancer; 2022 Apr; 22(1):394. PubMed ID: 35413826
[TBL] [Abstract][Full Text] [Related]
4. ADAM12 Is a Novel Regulator of Tumor Angiogenesis via STAT3 Signaling.
Roy R; Dagher A; Butterfield C; Moses MA
Mol Cancer Res; 2017 Nov; 15(11):1608-1622. PubMed ID: 28765266
[TBL] [Abstract][Full Text] [Related]
5. ADAM12 abrogation alters immune cell infiltration and improves response to checkpoint blockade therapy in the T11 murine model of triple-negative breast cancer.
Wang G; Romero Y; Thevarajan I; Zolkiewska A
Oncoimmunology; 2023; 12(1):2158006. PubMed ID: 36545255
[TBL] [Abstract][Full Text] [Related]
6. An ADAM12 and FAK positive feedback loop amplifies the interaction signal of tumor cells with extracellular matrix to promote esophageal cancer metastasis.
Luo ML; Zhou Z; Sun L; Yu L; Sun L; Liu J; Yang Z; Ran Y; Yao Y; Hu H
Cancer Lett; 2018 May; 422():118-128. PubMed ID: 29476791
[TBL] [Abstract][Full Text] [Related]
7. ADAM12-L confers acquired 5-fluorouracil resistance in breast cancer cells.
Wang X; Wang Y; Gu J; Zhou D; He Z; Wang X; Ferrone S
Sci Rep; 2017 Aug; 7(1):9687. PubMed ID: 28852196
[TBL] [Abstract][Full Text] [Related]
8. ADAM12 is an independent predictor of poor prognosis in liver cancer.
Du S; Sun L; Wang Y; Zhu W; Gao J; Pei W; Zhang Y
Sci Rep; 2022 Apr; 12(1):6634. PubMed ID: 35459884
[TBL] [Abstract][Full Text] [Related]
9. ADAM12 is A Potential Therapeutic Target Regulated by Hypomethylation in Triple-Negative Breast Cancer.
Mendaza S; Ulazia-Garmendia A; Monreal-Santesteban I; Córdoba A; Azúa YR; Aguiar B; Beloqui R; Armendáriz P; Arriola M; Martín-Sánchez E; Guerrero-Setas D
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32019179
[TBL] [Abstract][Full Text] [Related]
10. ADAM12 promotes clear cell renal cell carcinoma progression and triggers EMT via EGFR/ERK signaling pathway.
Xu J; Wang Y; Jiang J; Yin C; Shi B
J Transl Med; 2023 Jan; 21(1):56. PubMed ID: 36717944
[TBL] [Abstract][Full Text] [Related]
11. Elevation of ADAM12 facilitates tumor progression by enhancing metastasis and immune infiltration in gastric cancer.
Zhu H; Jiang W; Zhu H; Hu J; Tang B; Zhou Z; He X
Int J Oncol; 2022 May; 60(5):. PubMed ID: 35315496
[TBL] [Abstract][Full Text] [Related]
12. ADAM metallopeptidase domain 12 overexpression correlates with prognosis and immune cell infiltration in clear cell renal cell carcinoma.
Gao J; Yang D; Xu H; Yang K; Ma J; Xia J; Pan X
Bioengineered; 2022 Feb; 13(2):2412-2429. PubMed ID: 35094638
[TBL] [Abstract][Full Text] [Related]
13. FOXC2/ADAM12-dependent radiosensitivity of head and neck squamous cell carcinoma cells.
Jing Z; Guo S; Li Y; Liang Z
Head Neck; 2022 Jan; 44(1):212-225. PubMed ID: 34731528
[TBL] [Abstract][Full Text] [Related]
14. ADAM12 is a prognostic factor associated with an aggressive molecular subtype of high-grade serous ovarian carcinoma.
Cheon DJ; Li AJ; Beach JA; Walts AE; Tran H; Lester J; Karlan BY; Orsulic S
Carcinogenesis; 2015 Jul; 36(7):739-47. PubMed ID: 25926422
[TBL] [Abstract][Full Text] [Related]
15. Erbb2 up-regulation of ADAM12 expression accelerates skin cancer progression.
Rao VH; Vogel K; Yanagida JK; Marwaha N; Kandel A; Trempus C; Repertinger SK; Hansen LA
Mol Carcinog; 2015 Oct; 54(10):1026-36. PubMed ID: 24798404
[TBL] [Abstract][Full Text] [Related]
16. ADAM12 promotes gemcitabine resistance by activating EGFR signaling pathway and induces EMT in bladder cancer.
Wang R; Gao D; Chen C; Fan G; Cheng H; Tao Y; Lu J; Tian J; Wang Y; Wang Z
Clin Transl Oncol; 2023 May; 25(5):1425-1435. PubMed ID: 36512304
[TBL] [Abstract][Full Text] [Related]
17. Increased ADAM12 Expression Predicts Poor Prognosis in Cervical Cancer Patients before General Anesthesia.
Ma X; Wu Z; Zhang J; Shao X; Shen H
Clin Lab; 2021 Feb; 67(2):. PubMed ID: 33616346
[TBL] [Abstract][Full Text] [Related]
18. miR-29a-3p enhances the radiosensitivity of oral squamous cell carcinoma cells by inhibiting ADAM12.
Jiang C; Liu F; Xiao S; He L; Wu W; Zhao Q
Eur J Histochem; 2021 Sep; 65(3):. PubMed ID: 34587717
[TBL] [Abstract][Full Text] [Related]
19. Expression of
Chung MW; Park YL; Park SY; Joo YE
In Vivo; 2022; 36(5):2194-2204. PubMed ID: 36099146
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-130a modulates a radiosensitivity of rectal cancer by targeting SOX4.
Ha Thi HT; Kim HY; Kim YM; Hong S
Neoplasia; 2019 Sep; 21(9):882-892. PubMed ID: 31387015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]